Now Foods Ultra Omega-3 Softgels Review

Two things you give up. First, certification depth: Now Foods uses lot-coded third-party testing (mercury, heavy metals, potency) at a GMP-certified NPA-audited facility — solid but not IFOS 5-star public batch reports. Nordic Naturals (#1) lets you pull a Certificate of Analysis for your specific bottle by lot number on the brand's site; Now Foods makes you request one by email. Second, form specificity: Now Foods labels this as 'concentrated softgels,' which functionally means a TG-blend rather than the pure re-esterified TG form of premium brands. For most non-clinical use cases the absorption delta is minor, but at the precision tier, Nordic Naturals' rTG is verifiably better-absorbing per Dyerberg 2010.

Three reasons: (1) Now Foods' supply chain runs at volume — they manufacture across hundreds of SKUs and amortise QC overhead, (2) they skip the IFOS certification fee structure (~$2-5/bottle cost), and (3) the 500/250 EPA/DHA balance is achievable with less aggressive concentration than Nordic Naturals' 650/450 — slightly cheaper to produce. None of those are quality compromises in the meaningful sense; they're just cost-structure differences. The QC track record (35+ years, no major recalls on the omega-3 line) is the real reassurance.

Yes — that's the entire reason this bottle is a serious budget pick rather than a token grocery-aisle product. At 2 softgels with breakfast, you're inside the 1-2 g/day general-health Omega-3 Index correction window, and 3 softgels (2250 mg combined) lands you in the lower band of the 2-4 g/day cardiovascular protocol. The trial-aligned dose is achievable at this bottle, which is what separates Now Foods Ultra from cheaper '300 mg fish oil' tubs that would require 6+ caps to reach the same actives.

Some — but not catastrophically. The mercury and PCB risk is real for fish oil broadly, but Now Foods runs third-party heavy-metal testing on every lot and the facility is NPA-certified. They publish a Certificate of Analysis on request (email customer service with the lot number). The honest trade: Nordic Naturals (#1) lets you pull a Certificate of Analysis by lot number on its own site, and the IFOS-listed Carlson (#2) and Sports Research (#3) can be checked in the certifier's database; Now Foods requires you to request the COA. For the budget-constrained buyer, the brand-level QC track record is sufficient reassurance for most use cases — but if you're a hyper-careful buyer who wants independent listing, pay the premium for an IFOS-listed pick.

Likely yes, in two ways. First, the EPA+DHA-per-cap is much higher — grocery-aisle 'fish oil 1000 mg' typically delivers ~300 mg actives, vs Now Foods' 750 mg per cap. That means you're hitting the trial window at 2 caps instead of 4-5 caps. Second, the burp profile is better — Now Foods' molecular-distilled concentrate produces less fishy burp than cheap unconcentrated EE. Adherence is significantly higher, which means you'll actually finish bottle 1 instead of quitting at week 2.

On cycle two, after you've validated whether you respond. The honest discovery path: run Now Foods at 2-3 softgels/day for 12 weeks, get a follow-up lipid panel and Omega-3 Index test ($50 from omegaquest.com). If you respond on bloodwork and the supplement is now part of your standing protocol, upgrading to Nordic Naturals Ultimate Omega (#1) on bottle 2 gets you better rTG-form absorption and a lot-number Certificate of Analysis on the brand's site for ~$20/month more. If you're a non-responder, you've spent $36 finding out instead of $76.

1. [1] Mozaffarian 2011 PMID 22051327 — Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Comprehensive review establishing 10-33% triglyceride reduction at 2-4 g/day combined EPA+DHA. The cardiovascular dose justification underwriting the 2-3 cap/day Now Foods protocol for users targeting the lipid-panel endpoint.
2. [2] Harris 2008 (Omega-3 Index) PMID 15208005 — The omega-3 index: a new risk factor for death from coronary heart disease?. Defined the Omega-3 Index (RBC EPA+DHA as % of total fatty acids) as a CV risk biomarker. Index of 8%+ associated with the lowest CHD mortality — the target Now Foods Ultra Omega-3 at 2 caps/day reliably moves toward across a 12-week protocol.
3. [3] Dyerberg 2010 (TG vs EE bioavailability) PMID 20638827 — Bioavailability of marine n-3 fatty acid formulations. Direct head-to-head bioavailability of TG vs EE forms — 30-50% gap favouring TG. Now Foods' 'concentrated softgel' is a TG-blend; absorption is in the better half of the spectrum but not at the pure rTG benchmark of Nordic Naturals.
4. [4] Bhatt 2019 (REDUCE-IT) PMID 30415628 — Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. 4 g/day icosapent ethyl reduced major cardiovascular events by 25%. The trial that anchors the upper-bound 2-4 g/day cardiovascular protocol — Now Foods Ultra at 3-4 caps/day approximates a balanced version of this dose at one-tenth the prescription cost.
5. [5] Serhan 2014 (resolvins) PMID 24899309 — Pro-resolving lipid mediators are leads for resolution physiology. Mapped the resolvin and protectin biosynthesis pathway from EPA + DHA — the molecular mechanism behind omega-3's anti-inflammatory effect. The pathway runs the same regardless of whether the EPA+DHA comes from a premium IFOS bottle or Now Foods' lot-coded concentrate — what matters is the dose hitting the bloodstream.